Vita Life Sciences Limited

ASX:VLS Voorraadrapport

Marktkapitalisatie: AU$118.4m

Vita Life Sciences Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Vita Life Sciences heeft een totaal eigen vermogen van A$48.7M en een totale schuld van A$0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk A$68.0M en A$19.3M. De EBIT Vita Life Sciences is A$12.1M waardoor de rentedekking -13.1 is. Het heeft contanten en kortetermijnbeleggingen van A$27.7M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

AU$0

Schuld

Rente dekkingsratio-13.1x
ContantAU$27.75m
AandelenAU$48.70m
Totaal verplichtingenAU$19.25m
Totaal activaAU$67.95m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 23
Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Aug 28
Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22
Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14
Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28
Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Dec 20
A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

Aug 24
Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

May 14
If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Mar 18
Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 17
Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Jan 20
Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Dec 22
Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 19
Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Jul 14
Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$56.3M ) VLS } overtreffen de korte termijn passiva ( A$19.0M ).

Langlopende schulden: De kortetermijnactiva VLS ( A$56.3M ) overtreffen de langetermijnschulden ( A$236.0K ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: VLS is schuldenvrij.

Schuld verminderen: VLS heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 9% was.

Schuldendekking: VLS heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: VLS heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven